Cancer Exosomes Express CD39 and CD73, Which Suppress T Cells through Adenosine Production
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Extracellular adenosine is elevated in cancer tissue, and it negatively regulates local immune responses. Adenosine production from extracellular ATP has attracted attention as a mechanism of regulatory T cell-mediated immune regulation. In this study, we examined whether small vesicles secreted by cancer cells, called exosomes, contribute to extracellular adenosine production and hence modulate immune effector cells indirectly. We found exosomes from diverse cancer cell types exhibit potent ATP- and 5'AMP-phosphohydrolytic activity, partly attributed to exosomally expressed CD39 and CD73, respectively. Comparable levels of activity were seen with exosomes from pleural effusions of mesothelioma patients. In such fluids, exosomes accounted for 20% of the total ATP-hydrolytic activity. Exosomes can perform both hydrolytic steps sequentially to form adenosine from ATP. This exosome-generated adenosine can trigger a cAMP response in adenosine A(2A) receptor-positive but not A(2A) receptor-negative cells. Similarly, significantly elevated cAMP was also triggered in Jurkat cells by adding exosomes with ATP but not by adding exosomes or ATP alone. A proportion of healthy donor T cells constitutively express CD39 and/or CD73. Activation of T cells by CD3/CD28 cross-linking could be inhibited by exogenously added 5'AMP in a CD73-dependent manner. However, 5'AMP converted to adenosine by exosomes inhibits T cell activation independently of T cell CD73 expression. This T cell inhibition was mediated through the adenosine A(2A) receptor. In summary, the data highlight exosome enzymic activity in the production of extracellular adenosine, and this may play a contributory role in negative modulation of T cells in the tumor environment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Clayton et al. reported the expression of CD39, CD73, and eADO in MPM-derived exosome from pleural effusion, contributing to the inhibition of T cell functions [133].”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [133]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids
Théry, C., Amigorena, S., Raposo, G., & Clayton, A. (2006) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0322s30 · Cited by 5,766 · cited 1×
“To quantify the density of exosomes, we used a protocol similar to that previously described, based on ultracentrifugation on a linear sucrose gradient (36).”
MethodSelf-citationMembrane vesicles as conveyors of immune responses
Théry, C., Ostrowski, M., & Segura, E. (2009) · Nature Reviews Immunology · doi:10.1038/nri2567 · Cited by 3,882 · cited 1×
“immune-activating functions, there are also accumulating data pointing to varied suppressive effects (40).”
BackgroundB lymphocytes secrete antigen-presenting vesicles.
Raposo, G., Nijman, H. W., Stoorvogel, W., Liejendekker, R., Harding, C. V., Melief, C. J., & Geuze, H. J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.1161 · Cited by 3,546 · cited 1×
“The density (g/ml) of each fraction was calculated from the published table in the Beckman Ultracentrifugation catalogue as described (37).”
MethodDeaglio, S., Dwyer, K. M., Gao, W., Friedman, D., Usheva, A., Erat, A., Chen, J.-F., Enjyoji, K., Linden, J., Oukka, M., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062512 · Cited by 2,470 · cited 5×
“These are double-positive for CD39 and CD73 in mice (12) and according to one report also in human (45).”
BackgroundInfluentialOhta, A., & Sitkovsky, M. (2001) · Nature · doi:10.1038/414916a · Cited by 1,334
Borsellino, G., Kleinewietfeld, M., Di Mitri, D., Sternjak, A., Diamantini, A., Giometto, R., Höpner, S., Centonze, D., Bernardi, G., Dell'Acqua, M. L., et al. (2007) · Blood · doi:10.1182/blood-2006-12-064527 · Cited by 1,286 · cited 3×
“Natural regulatory T cells of mice express both CD39 and CD73, whose coordinated enzymatic actions produce adenosine as a mechanism for immune suppression that is independent of IL-10 and TGF-b (12, 13).”
BackgroundAdenosine receptors: therapeutic aspects for inflammatory and immune diseases
Haskó, G., Linden, J., Cronstein, B., & Pacher, P. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2638 · Cited by 1,217 · cited 1×
“mechanisms involved in adenosine formation and subsequent signaling are therefore of considerable therapeutic interest (9).”
BackgroundA2A adenosine receptor protects tumors from antitumor T cells
Ohta, A., Gorelik, E., Prasad, S. J., Ronchese, F., Lukashev, D., Wong, M. K. K., Huang, X., Caldwell, S., Liu, K., Smith, P., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605251103 · Cited by 1,065 · cited 1×
“Adenosine also represses immune responses in the tumor microenvironment, assisting tumor immune evasion (7, 8).”
BackgroundMalignant effusions and immunogenic tumour-derived exosomes
Andre, F., Schartz, N. E., Movassagh, M., Flament, C., Pautier, P., Morice, P., Pomel, C., Lhomme, C., Escudier, B., Le Chevalier, T., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09552-1 · Cited by 953 · cited 7×
“The cushion was collected and exosomes washed in PBS (32, 34, 35).”
MethodInfluentialExoCarta: A compendium of exosomal proteins and RNA
Mathivanan, S., & Simpson, R. J. (2009) · PROTEOMICS · doi:10.1002/pmic.200900351 · Cited by 873
Production and characterization of clinical grade exosomes derived from dendritic cells
Lamparski, H. G., Metha-Damani, A., Yao, J.-Y., Patel, S., Hsu, D.-H., Ruegg, C., & Le Pecq, J.-B. (2002) · Journal of Immunological Methods · doi:10.1016/s0022-1759(02)00330-7 · Cited by 700 · cited 7×
“The cushion was collected and exosomes washed in PBS (32, 34, 35).”
MethodInfluentialHuman Tumor-Derived Exosomes Down-Modulate NKG2D Expression
Clayton, A., Mitchell, J. P., Court, J., Linnane, S., Mason, M. D., & Tabi, Z. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7249 · Cited by 574 · cited 4×
“impaired cytolytic functions and Treg induction (32), downregulation of activating receptors like NKG2D (31), and negative effects also on APCs (42).”
BackgroundSelf-citationAnti-CD73 antibody therapy inhibits breast tumor growth and metastasis
Stagg, J., Divisekera, U., McLaughlin, N., Sharkey, J., Pommey, S., Denoyer, D., Dwyer, K. M., & Smyth, M. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908801107 · Cited by 572 · cited 1×
“tasis (16) but also by freeing antitumor T cells from the suppressive effects of extracellular adenosine (15, 17).”
BackgroundHuman Tumor-Derived Exosomes Selectively Impair Lymphocyte Responses to Interleukin-2
Clayton, A., Mitchell, J. P., Court, J., Mason, M. D., & Tabi, Z. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3456 · Cited by 520 · cited 10×
“The cushion was collected and exosomes washed in PBS (32, 34, 35).”
BackgroundMethodSelf-citationZarek, P. E., Huang, C.-T., Lutz, E. R., Kowalski, J., Horton, M. R., Linden, J., Drake, C. G., & Powell, J. D. (2008) · Blood · doi:10.1182/blood-2007-03-081646 · Cited by 515 · cited 1×
“The same receptor can attenuate NK cell cytokine production and cytotoxic activity (26, 27), and promote the generation of regulatory T cells (Treg) (28).”
Background(1997) · PubMed · Cited by 433
Jin, D., Fan, J., Wang, L., Thompson, L. F., Liu, A., Daniel, B. J., Shin, T., Curiel, T. J., & Zhang, B. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3109 · Cited by 432 · cited 2×
“Several cancer cell types also express CD73 (14, 15) and CD39 (15) suggesting cancers can produce adenosine from extracellular substrate directly, without the requirement of nucleotidases ex-”
BackgroundTumor exosomes inhibit differentiation of bone marrow dendritic cells
Yu, S., Liu, C., Su, K., Wang, J., Liu, Y., Zhang, L., Li, C., Cong, Y., Kimberly, R., Grizzle, W. E., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.6867 · Cited by 425 · cited 2×
“impaired cytolytic functions and Treg induction (32), downregulation of activating receptors like NKG2D (31), and negative effects also on APCs (42).”
BackgroundProteomic Analysis of Exosomes Isolated from Human Malignant Pleural Effusions
Bard, M. P., Hegmans, J. P., Hemmes, A., Luider, T. M., Willemsen, R., Severijnen, L.-A. A., van Meerbeeck, J. P., Burgers, S. A., Hoogsteden, H. C., & Lambrecht, B. N. (2004) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0238oc · Cited by 416 · cited 1×
“This fluid is a tumor effusion previously described by us and others as containing exosomes (31, 39), and although it does not represent the tumor microenvironment per se, it does reflect an in vivo tumorconditioned environment.”
BackgroundTumour-derived exosomes and their role in cancer-associated T-cell signalling defects
Taylor, D. D., & Gerçel-Taylor, C. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602316 · Cited by 391 · cited 1×
“Documented mechanisms include induction of T cell apoptosis (41), TGF-b–mediated”
BackgroundMandapathil, M., Hilldorfer, B., Szczepanski, M. J., Czystowska, M., Szajnik, M., Ren, J., Lang, S., Jackson, E. K., Gorelik, E., & Whiteside, T. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.047423 · Cited by 390 · cited 2×
“These are double-positive for CD39 and CD73 in mice (12) and according to one report also in human (45).”
BackgroundResultProteomics Analysis of Bladder Cancer Exosomes
Welton, J. L., Khanna, S., Giles, P. J., Brennan, P., Brewis, I. A., Staffurth, J., Mason, M. D., & Clayton, A. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m000063-mcp201 · Cited by 387
Self-citationA2A Adenosine Receptor Induction Inhibits IFN-γ Production in Murine CD4+ T Cells
Lappas, C. M., Rieger, J. M., & Linden, J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.1073 · Cited by 385
Hoskin, D., Mader, J., Furlong, S., Conrad, D., & Blay, J. (2008) · International Journal of Oncology · doi:10.3892/ijo.32.3.527 · Cited by 242 · cited 1×
“Adenosine also represses immune responses in the tumor microenvironment, assisting tumor immune evasion (7, 8).”
BackgroundCutting Edge: Critical Role for A2A Adenosine Receptors in the T Cell-Mediated Regulation of Colitis
Naganuma, M., Wiznerowicz, E. B., Lappas, C. M., Linden, J., Worthington, M. T., & Ernst, P. B. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.2765 · Cited by 240 · cited 1×
“colitis (1), diabetes (2), asthma (3), sepsis (4), and ischemic injury (5, 6).”
BackgroundDay, Y.-J., Huang, L., Ye, H., Li, L., Linden, J., & Okusa, M. D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.5.3108 · Cited by 209 · cited 1×
“colitis (1), diabetes (2), asthma (3), sepsis (4), and ischemic injury (5, 6).”
BackgroundKansas, G. S., Wood, G. S., & Tedder, T. F. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.7.2235 · Cited by 207 · cited 1×
“The broad distribution of these nucleotidases by other lymphocyte subsets in humans is known (46) but has only recently been examined in terms of functional importance (47).”
BackgroundReutershan, J., Vollmer, I., Stark, S., Wagner, R., Ngamsri, K., & Eltzschig, H. K. (2009) · The FASEB Journal · doi:10.1096/fj.08-119701 · Cited by 200 · cited 8×
“To address possible involvement of CD39 in ATP hydrolysis, sucrose cushion-purified exosomes were assessed for ATP hydrolysis in the presence of increasing doses of POM-1, an inhibitor of CD39 (38).”
BackgroundInfluentialThe role of CD26/dipeptidyl peptidase IV in cancer
Havre, P. (2008) · Frontiers in Bioscience · doi:10.2741/2787 · Cited by 198 · cited 1×
“downregulation of CD26, which binds adenosine deaminase to the cell surface (11).”
BackgroundThorn, J. A., & Jarvis, S. M. (1996) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(95)02053-5 · Cited by 194
Day, Y.-J., Marshall, M. A., Huang, L., McDuffie, M. J., Okusa, M. D., & Linden, J. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00348.2003 · Cited by 183 · cited 1×
“colitis (1), diabetes (2), asthma (3), sepsis (4), and ischemic injury (5, 6).”
BackgroundGs Protein-Coupled Adenosine Receptor Signaling and Lytic Function of Activated NK Cells
Raskovalova, T., Huang, X., Sitkovsky, M., Zacharia, L. C., Jackson, E. K., & Gorelik, E. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4383 · Cited by 175 · cited 1×
“The same receptor can attenuate NK cell cytokine production and cytotoxic activity (26, 27), and promote the generation of regulatory T cells (Treg) (28).”
BackgroundKoshiba, M., Rosin, D. L., Hayashi, N., Linden, J., & Sitkovsky, M. V. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12188-8 · Cited by 169 · cited 2×
“affinity A2A receptor, which becomes elevated after cell activation (23).”
BackgroundThe A2B Adenosine Receptor Impairs the Maturation and Immunogenicity of Dendritic Cells
Wilson, J. M., Ross, W. G., Agbai, O. N., Frazier, R., Figler, R. A., Rieger, J. M., Linden, J. M., & Ernst, P. B. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801279 · Cited by 158 · cited 1×
“impairs maturation and function of dendritic cells, but these effects are mediated principally through the A2B receptor (29).”
BackgroundErdmann, A. A., Gao, Z., Jung, U., Foley, J., Borenstein, T., Jacobson, K. A., & Fowler, D. H. (2005) · Blood · doi:10.1182/blood-2004-04-1407 · Cited by 156 · cited 1×
“This pathway can inhibit responses to IL-2 and TCR ligation providing a potent mode for attenuating multiple T cell effector functions (19, 25).”
BackgroundZhi, X., Chen, S., Zhou, P., Shao, Z., Wang, L., Ou, Z., & Yin, L. (2007) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9081-y · Cited by 149 · cited 1×
“tasis (16) but also by freeing antitumor T cells from the suppressive effects of extracellular adenosine (15, 17).”
BackgroundRaskovalova, T., Lokshin, A. E., Huang, X., Su, Y., Mandić, M., Zarour, H. M., Jackson, E. K., & Gorelik, E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4249 · Cited by 142 · cited 1×
“This pathway can inhibit responses to IL-2 and TCR ligation providing a potent mode for attenuating multiple T cell effector functions (19, 25).”
BackgroundMoncrieffe, H., Nistala, K., Kamhieh, Y., Evans, J., Eddaoudi, A., Eaton, S. D., & Wedderburn, L. R. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0803474 · Cited by 142 · cited 3×
“(47) isolated CD39CD4Foxp3(2) T cells from arthritic patients and showed ATP-hydrolytic capacity of this nonTreg population.”
BackgroundIncreased exosome production from tumour cell cultures using the Integra CELLine Culture System
Mitchell, J. P., Court, J., Mason, M. D., Tabi, Z., & Clayton, A. (2008) · Journal of Immunological Methods · doi:10.1016/j.jim.2008.03.001 · Cited by 137 · cited 1×
“) and maintained at high-density culture for exosome production as described (33).”
BackgroundSelf-citationA2B Adenosine Receptors Protect against Sepsis-Induced Mortality by Dampening Excessive Inflammation
Csóka, B., Németh, Z. H., Rosenberger, P., Eltzschig, H. K., Spolarics, Z., Pacher, P., Selmeczy, Z., Koscsó, B., Himer, L., Vizi, E. S., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901295 · Cited by 132 · cited 1×
“colitis (1), diabetes (2), asthma (3), sepsis (4), and ischemic injury (5, 6).”
BackgroundThomson, L., Ruedi, J. M., Glass, A. A., Moldenhauer, G., Mӧller, P., Low, M. G., Klemens, M. R., Massaia, M., & Lucas, A. H. (1990) · Tissue Antigens · doi:10.1111/j.1399-0039.1990.tb01750.x · Cited by 130
Zhang, H., Conrad, D., Butler, J. J., Zhao, C., Blay, J., & Hoskin, D. W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.932 · Cited by 119 · cited 1×
“Signals emanating from A2A trigger intracellular cAMP production (23) and increase Src-homology region 2 domain-containing phosphatase-2, dephosphorylating STAT-5 (24).”
BackgroundAdenosine receptor activation ameliorates type 1 diabetes
Nemeth, Z. H., Bleich, D., Csóka, B., Pacher, P., Mabley, J. G., Himer, L., Vizi, E. S., Deitch, E. A., Szabó, C., Cronstein, B. N., et al. (2007) · The FASEB Journal · doi:10.1096/fj.07-8213com · Cited by 103 · cited 1×
“colitis (1), diabetes (2), asthma (3), sepsis (4), and ischemic injury (5, 6).”
BackgroundDifferential ectonucleotidase expression in human bladder cancer cell lines
Stella, J., Bavaresco, L., Braganhol, E., Rockenbach, L., Farias, P. F., Wink, M. R., Azambuja, A. A., Barrios, C. H., Morrone, F. B., & Battastini, A. M. O. (2009) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2009.01.035 · Cited by 90 · cited 1×
“Several cancer cell types also express CD73 (14, 15) and CD39 (15) suggesting cancers can produce adenosine from extracellular substrate directly, without the requirement of nucleotidases ex-”
BackgroundOstler, T., & Ehl, S. R. (2002) · Journal of Immunological Methods · doi:10.1016/s0022-1759(02)00191-6 · Cited by 68
Adenosine receptors and modulation of natural killer cell activity by purine nucleosides.
Priebe, T. S., Platsoucas, C. D., & Nelson, J. A. (1990) · PubMed · Cited by 54
Adenosine inhibits the release of interleukin-1β in activated human peripheral mononuclear cells
Sipka, S., Kovács, I., Szántó, S., Szegedi, G., Brúgós, L., Bruckner, G. G., & Szentmiklosi, A. J. (2005) · Cytokine · doi:10.1016/j.cyto.2005.05.002 · Cited by 42
Role of adenosine in airway inflammation in an allergic mouse model of asthma
Fan, M., & Mustafa, S. J. (2005) · International Immunopharmacology · doi:10.1016/j.intimp.2005.07.008 · Cited by 41 · cited 1×
“colitis (1), diabetes (2), asthma (3), sepsis (4), and ischemic injury (5, 6).”
BackgroundAdenosine and IFN-α synergistically increase IFN-γ production of human NK cells
Jeffe, F., Stegmann, K. A., Broelsch, F., Manns, M. P., Cornberg, M., & Wedemeyer, H. H. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0108046 · Cited by 17
Cited by
The biology , function , and biomedical applications of exosomes
Kalluri, R., & LeBleu, V. S. (2020) · Science · doi:10.1126/science.aau6977 · Cited by 10,770
Pegtel, D. M., & Gould, S. J. (2019) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-013118-111902 · Cited by 2,682
Molecular principles of metastasis: a hallmark of cancer revisited
Fares, J., Fares, M. Y., Khachfe, H. H., Salhab, H. A., & Fares, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0134-x · Cited by 2,379
Exosomes: biogenesis, biologic function and clinical potential
Zhang, Y., Liu, Y., Liu, H., & Tang, W. H. (2019) · Cell & Bioscience · doi:10.1186/s13578-019-0282-2 · Cited by 2,119
Classification, Functions, and Clinical Relevance of Extracellular Vesicles
van der Pol, E., Böing, A. N., Harrison, P., Sturk, A., & Nieuwland, R. (2012) · Pharmacological Reviews · doi:10.1124/pr.112.005983 · Cited by 1,754
“Exosomes from pleural effusion of patients with mesothelioma contained 20% of the total ATP-hydrolytic activity, indicating that exosomes may contribute to inhibition of T cells in the tumor environment by this mechanism (Clayton et al., 2011).”
Background
Metadata
- Authors
- Clayton, A., Al-Taei, S., Webber, J., Mason, M. D., & Tabi, Z.
- Affiliations
- Velindre Cancer Centre (GB)
- Department of Pharmacology, Radiology and Oncology, School of Medicine, Cardiff University, Velindre Cancer Centre , Whitchurch, Cardiff CF14 2TL ,
- Corresponding author
- Clayton, Aled
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-07
- Volume
- 187
- Issue
- 2
- Pages
- 676-683
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2153092839
- Cited by
- 540
- References
- 49
- Citations by year
- 2026: 18 · 2025: 30 · 2024: 31 · 2023: 38 · 2022: 53 · 2021: 50 · 2020: 61 · 2019: 37 · 2018: 36 · 2017: 29 · 2016: 30 · 2015: 24 · 2014: 33 · 2013: 26 · 2012: 40
- FWCI
- 23.02
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Keywords
- tumor-derived exosomes, CD39, CD73, extracellular adenosine, ATP hydrolysis, 5'-AMP, adenosine A2A receptor, cAMP signaling, T cell activation inhibition, tumor immunosuppression, mesothelioma, extracellular vesicles
- MeSH terms
- Adenosine, Adenosine Monophosphate, Adenosine Triphosphate, Apyrase, Humans, Hydrolysis, Mesothelioma, Phosphorylation, Pleural Neoplasms, Down-Regulation, Antigens, CD, 5'-Nucleotidase, Caco-2 Cells, Jurkat Cells, Cell Line, Tumor, T-Lymphocytes, Regulatory, Exosomes, GPI-Linked Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.